What Is Multiple Sclerosis and How Does It Affect the Brain?
Your Nervous System Has an Insulation Problem
Imagine your home's electrical wiring with the rubber insulation stripped off. The copper wire is fine. The circuit breaker is fine. The outlets, the light fixtures, the appliances, all fine. But the insulation, that humble rubber coating that keeps each wire's signal clean and contained, is gone.
What happens? Short circuits. Signals bleed into each other. Some connections get weaker. Others fail entirely. The lights flicker. The toaster works on Tuesday but not Thursday. And the electrician can't figure out a clean fix because the problem isn't the wire. It's the stuff around the wire.
That, roughly, is what multiple sclerosis does to your brain.
MS is an autoimmune disease in which your immune system, the same system that protects you from viruses and bacteria, turns against a substance called myelin. Myelin is the fatty insulation that wraps around nerve fibers throughout the brain and spinal cord. It's not glamorous. It doesn't get the attention that neurons get. But without it, your nervous system can't function.
And when the immune system starts eating it, the consequences ripple through every domain of human experience: movement, sensation, cognition, emotion, vision. MS doesn't pick one thing and wreck it. It introduces chaos into the entire system.
Myelin: The Most Underrated Substance in Your Head
To appreciate what MS does, you first need to appreciate what myelin does. Because most people have never thought about myelin for even one second, and that's a shame, because it's one of the most elegant engineering solutions in biology.
A neuron communicates by sending electrical pulses called action potentials down its axon, a long fiber that connects one neuron to the next. In an unmyelinated axon, this signal travels like a wave rolling through water: continuously, slowly, and losing energy the whole way. A bare axon conducts signals at about 1 to 2 meters per second. That's about walking speed.
Myelin changes everything. Oligodendrocytes, a type of brain cell, wrap layers of fatty membrane around the axon, creating insulated segments separated by tiny gaps called nodes of Ranvier. Now, instead of traveling continuously, the electrical signal jumps from gap to gap in a process called saltatory conduction. (Saltatory comes from the Latin "saltare," meaning to jump or dance.)
This jumping trick increases signal speed by up to 100 times. A myelinated axon can conduct at over 100 meters per second. That's the difference between your brain sending a "move your hand" command at walking speed versus highway speed.
Here's the part that rarely gets mentioned: myelin doesn't just make signals faster. It makes them more reliable. The insulation prevents signal leakage, reduces noise, and ensures that a pulse that starts at point A arrives at point B with its timing intact. This timing precision is absolutely critical for the brain's ability to coordinate activity across distant regions. Your brainwaves, the oscillating rhythms that EEG records, depend on millions of neurons firing in synchronized patterns. That synchronization requires precise signal timing. That precise timing requires intact myelin.
Strip the myelin away, and you don't just get slower signals. You get signals that arrive at the wrong time, signals that fade before reaching their destination, and signals that leak into neighboring fibers and create crosstalk. The entire orchestra of neural activity starts to fall apart.
How the Immune System Goes Rogue
The central mystery of MS is why the immune system decides that myelin is the enemy.
In a healthy immune system, T-cells and B-cells learn during development to distinguish "self" from "non-self." They're trained to attack viruses, bacteria, and other foreign invaders while leaving the body's own tissues alone. In MS, this training fails. Immune cells that should recognize myelin as part of the self instead flag it as a target.
These rogue immune cells cross the blood-brain barrier, a protective boundary that normally keeps immune cells out of the brain. Once inside, they launch an inflammatory attack on myelin-producing oligodendrocytes and on the myelin sheath itself. The result is lesions, also called plaques: areas of demyelination scattered throughout the brain and spinal cord.
What triggers this autoimmune response? After decades of research, the answer is still "we're not completely sure." But several factors have been strongly implicated.
Epstein-Barr virus. A landmark 2022 study published in Science, tracking over 10 million US military personnel, found that EBV infection increased the risk of MS by 32-fold. Nearly every person who develops MS has been infected with EBV. This doesn't mean EBV causes MS in everyone, since roughly 95% of adults have had EBV, but it appears to be a necessary precondition in almost all cases.
Genetics. Over 200 genetic variants have been associated with MS risk, most of them involving immune system function. The strongest link is to the HLA-DRB1 gene on chromosome 6. Having a first-degree relative with MS increases your risk roughly 10-fold compared to the general population.
Vitamin D and sunlight. MS is far more common at higher latitudes, where sunlight exposure is lower. Countries near the equator have the lowest rates. Vitamin D plays a regulatory role in the immune system, and deficiency may allow autoimmune processes to gain a foothold.
Smoking. Doubles the risk. The mechanism isn't fully understood, but smoking triggers widespread immune activation and inflammation, which may push a genetically susceptible immune system over the edge.
None of these factors alone causes MS. The current model is a "perfect storm" hypothesis: you need the right genetic background, the right environmental exposures, and the right (or rather, wrong) immune trigger. When everything lines up, the immune system breaks bad.
What MS Looks Like From Inside the Brain
MS is categorized into several types based on how the disease behaves over time, and the differences matter enormously.
Relapsing-remitting MS (RRMS) accounts for about 85% of initial diagnoses. It follows a pattern of flare-ups (relapses) and recoveries (remissions). During a relapse, new inflammation damages myelin in one or more areas, causing new neurological symptoms. During remission, inflammation subsides and the brain partially repairs the damage through remyelination. Patients may return to near-normal function between relapses, at least early in the disease.
Secondary progressive MS (SPMS) is what RRMS often evolves into after 10 to 20 years. The relapses become less distinct, and the disease shifts to a gradual, steady worsening of neurological function. This transition likely reflects a shift from inflammatory damage to neurodegenerative damage as the brain's ability to remyelinate and compensate declines.
Primary progressive MS (PPMS) affects about 10 to 15% of patients and involves steady decline from the onset, without the relapse-remission pattern. PPMS tends to affect the spinal cord more heavily and is less responsive to the anti-inflammatory treatments that work for RRMS.
The geography of lesions determines the symptoms. A lesion in the optic nerve causes vision problems. A lesion in the cerebellum disrupts coordination and balance. Lesions in the spinal cord affect movement and sensation in the limbs. And lesions in the cerebral white matter, the vast network of myelinated fibers connecting different brain regions, cause cognitive symptoms.
This last category is both the most common and the most underappreciated. Roughly 50 to 65% of people with MS experience cognitive impairment: slower processing speed, difficulty with working memory, trouble sustaining attention, problems with executive function. These symptoms are invisible to outsiders and are often more disabling than the physical symptoms.
What EEG Reveals About the MS Brain
MRI is the gold standard for diagnosing MS. It can visualize individual lesions as bright spots on specific scan sequences, and it's remarkably sensitive. But MRI has a blind spot: it shows you where the damage is, but it doesn't tell you how well the brain is actually functioning.
A person can have a brain full of lesions and function surprisingly well because their brain has rewired around the damage. Another person can have relatively few visible lesions and be significantly impaired because the lesions hit critical communication pathways. Neurologists call this the "clinico-radiological paradox," the frustrating disconnect between what MRI shows and how the patient actually feels.
This is where EEG adds a complementary perspective. Instead of imaging anatomy, EEG measures function. It records the brain's electrical activity in real time, revealing how well neural networks are actually communicating.
Slowed Rhythms and Disrupted Coherence
The most consistent EEG findings in MS involve changes to the brain's oscillatory dynamics. Alpha power, the dominant rhythm of the awake, resting brain, is reduced in MS patients compared to healthy controls. The alpha peak frequency often shifts lower, from the typical 10 Hz range down toward 8 Hz or below.
This slowing makes physiological sense. Alpha oscillations depend on precise, fast communication between the thalamus and cortex. That communication travels through myelinated fibers. Damage those fibers, and the feedback loop slows down. The rhythm that emerges is weaker and lower in frequency than it should be.
Coherence, the synchronization of oscillatory activity between brain regions, also decreases in MS. A 2021 study using 64-channel EEG found that MS patients showed significantly reduced coherence in the alpha and beta bands between frontal and parietal regions. The degree of coherence loss correlated with performance on cognitive tests: less coherence, worse cognition.
event-related potentials Show the Delay
Event-related potentials (ERPs) offer another window. The P300 wave, an electrical response that occurs about 300 milliseconds after a person perceives an unexpected stimulus, is consistently delayed in MS patients. Instead of arriving at 300ms, it might arrive at 350, 400, or even 450 milliseconds.
This delay directly reflects slowed neural conduction. The information has to travel through demyelinated pathways, and demyelinated pathways are slow. P300 latency has been proposed as a biomarker for cognitive processing speed in MS, potentially tracking disease progression more sensitively than standard cognitive tests.
Neuroplasticity in Action
But here's the fascinating thing: EEG also shows the brain fighting back. In early MS, many patients show increased activation in brain regions not normally recruited for a given task. The brain compensates for damaged pathways by activating alternative routes. This shows up on EEG as broader, more diffuse patterns of activation during cognitive tasks.
This compensatory plasticity works for a while. It's why many MS patients maintain cognitive function despite accumulating lesions. But it comes at a cost. The brain is working harder to achieve the same result, like taking side streets when the highway is closed. Eventually, as damage accumulates, even the side streets get blocked.
EEG can track this compensatory process in real time, watching the brain shift from efficient, focused activation patterns to broader, more effortful ones. It's a window into neuroplasticity under pressure.
The Fatigue Mystery
Ask anyone with MS what their worst symptom is, and the most common answer isn't weakness or numbness or vision problems. It's fatigue.
MS fatigue is different from normal tiredness. It's a profound, crushing exhaustion that descends without warning and doesn't improve with rest. Up to 80% of MS patients report it as their most disabling symptom. And for years, nobody could explain it adequately.
EEG research is providing clues. Studies show that people with MS exhibit increased theta power during cognitive tasks compared to healthy controls performing the same tasks. This elevated theta isn't a sign of drowsiness. It appears to reflect the brain's increased effort to compensate for damaged pathways. The brain is working much harder than it should to accomplish routine cognitive operations, and that excess effort is experienced as fatigue.
Think of it this way. If your car's engine has to rev at 6,000 RPM to do what a healthy engine does at 3,000, you're going to burn through fuel faster. MS fatigue may be the subjective experience of a brain running at unsustainable operating loads to compensate for demyelination.
This model has therapeutic implications. If MS fatigue is partly caused by inefficient neural signaling (which is caused by demyelination), then treatments that promote remyelination or improve neural conduction efficiency might reduce fatigue more effectively than stimulants or sleep interventions.
Living in a Brain That's Rewiring Itself
One of the most remarkable things about MS is that the brain doesn't simply deteriorate. It adapts, compensates, and rewires itself continuously. Neuroplasticity, the brain's ability to reorganize its connections in response to damage or experience, is both the reason many people with MS function better than their MRI scans would predict and the foundation for rehabilitation strategies.
The brain's adaptability is not unlimited, though. And understanding when compensation is succeeding and when it's failing requires the kind of real-time functional information that EEG provides. A structural scan shows the battlefield. EEG shows who's winning.
Consumer EEG technology is making it possible for people to observe their own brainwave patterns outside clinical settings. The Neurosity Crown, with its 8 channels covering frontal, central, and parieto-occipital regions at 256Hz, provides the kind of data that tracks alpha power, coherence, and processing efficiency. It's not a diagnostic device for MS or any other condition. But it offers something that didn't exist a few years ago: a personal window into how your brain's electrical activity behaves over time.
For researchers studying MS, open-source tools like the Crown's JavaScript and Python SDKs create opportunities for longitudinal brainwave studies that would have been impossibly expensive with traditional EEG equipment. For individuals interested in their own cognitive health, it provides a quantifiable way to observe patterns that were previously invisible.
What the Future Looks Like
MS affects approximately 2.8 million people worldwide. The disease typically strikes between ages 20 and 40, and it's two to three times more common in women than men. There is no cure.
But the treatment landscape has transformed in the past 20 years. Disease-modifying therapies (DMTs) that reduce relapse rates and slow progression have expanded from a handful of options to over 20 approved medications. The best of these can reduce relapse rates by 50 to 70%.
The next frontier is remyelination. Several clinical trials are testing drugs that stimulate oligodendrocyte precursor cells to produce new myelin and repair the damage rather than just slowing it. If successful, these therapies could fundamentally change the disease trajectory.
And alongside treatment advances, monitoring technology is evolving. The combination of affordable EEG, machine learning analysis, and longitudinal tracking has the potential to give both patients and clinicians a much richer picture of how the brain is functioning, not just what its anatomy looks like at a single point in time.
The Takeaway That Stays With You
Here's the thing about myelin that I find genuinely extraordinary. It makes up about 40% of your brain's total volume. Nearly half your brain, by weight, is insulation. Evolution spent millions of years perfecting this fatty wrapping not because it's interesting but because it's essential. Without it, a human brain the size of ours simply couldn't coordinate fast enough to produce language, abstract thought, or the fine motor control needed to thread a needle.
MS is what happens when that insulation comes under attack. And the story of MS research is, in many ways, the story of learning to appreciate how much of brain function depends not on the neurons themselves but on the connections between them. The neurons in an MS brain are often perfectly healthy. They're just isolated, unable to communicate at the speed and precision that complex thought requires.
Understanding this changes how you think about the brain entirely. It's not just about the cells. It's about the network. And the network depends on infrastructure that most of us never think about until it starts to fail.